Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.
Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG.
Verhoog LC, et al. Among authors: seynaeve c.
Lancet. 1998 Jan 31;351(9099):316-21. doi: 10.1016/s0140-6736(97)07065-7.
Lancet. 1998.
PMID: 9652611